These findings suggest that Notch1 could serve as a novel diagnostic and therapeutic target in patients with ICC and thereby establish the potential for targeting Notch signaling as an approach to inhibit tumor metastasis. Here, NOTCH1 is linked to intrahepatic cholangiocarcinoma.